KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Hologic (HOLX) Long-Term Investments (2024 - 2025)

Hologic's Long-Term Investments history spans 2 years, with the latest figure at $196.7 million for Q4 2025.

For Q4 2025, Long-Term Investments rose 310.65% year-over-year to $196.7 million; the TTM value through Dec 2025 reached $196.7 million, up 310.65%, while the annual FY2025 figure was $243.2 million, 152.28% up from the prior year.
Long-Term Investments for Q4 2025 was $196.7 million at Hologic, down from $243.2 million in the prior quarter.
Across five years, Long-Term Investments topped out at $243.2 million in Q3 2025 and bottomed at $47.9 million in Q4 2024.